Back to CITADEL ADVISORS LLC CITADEL ADVISORS LLC

LTRNLTRN
17 quarters

Position history for CITADEL ADVISORS LLCCITADEL ADVISORS LLC's holdings in LANTERN PHARMA INC

Yes. Citadel Advisors holds 47,895 shares of LTRN (Lantern Pharma), worth $199,722, as of its Q2 2026 13F filing. It opened the position in Q2 2026.

Current Value

$199,722

Current Shares

47,895

Total Value Change

-$3,278

Total Shares Change

+36,703

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
New
47,895
-
$199,7220.0%$4.17
35
2026-Q1
Exited
0
-100.0%
$00.0%$1.37
0
2025-Q4
New
32,895
-
$99,6720.0%$3.03
33
2025-Q1
Exited
0
-100.0%
$00.0%$3.54
0
2024-Q4
Increased
37,587
+1645.8%
$119,9030.0%$3.19
24
2024-Q3
New
2,153
-
$7,9020.0%$3.67
25
2024-Q1
Exited
0
-100.0%
$00.0%$8.80
0
2023-Q4
Decreased
24,858
-18.9%
$106,3920.0%$4.28
0
2023-Q3
Increased
30,632
+23.8%
$104,4550.0%$3.41
18
2023-Q2
Increased
24,737
+125.4%
$139,5170.0%$5.64
24
2023-Q1
Decreased
10,976
-43.2%
$53,0140.0%$4.83
0
2022-Q4
Increased
19,321
+51.5%
$116,6990.0%$6.04
21
2022-Q3
New
12,753
-
$61,0000.0%$4.78
32
2022-Q1
Exited
0
-100.0%
$00.0%$7.15
0
2021-Q4
New
11,095
-
$89,0000.0%$7.98
33
2021-Q2
Exited
0
-100.0%
$00.0%$14.60
0
2021-Q1
New
11,192
-
$203,0000.0%$18.14
35

Other major holders of LTRN: NewEdge Advisors, LLC, VANGUARD CAPITAL MANAGEMENT LLC, VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used